chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: I have been getting dizzy spells daily since getting the vaccine. I feel like I am going to fall down sometimes. I have no prior hx of dizziness.; This is a spontaneous report from a non-contactable consumer, the patient. A 40-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Er8734) via an unspecified route of administration in the left arm on 07Apr2021 at 16:15 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any medication within two weeks of vaccination. The patient previously took metoclopramide (REGLAN) and experienced drug allergy. The patient previously took ciprofloxacin (CIPRO) and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. From 07Apr2021 at 19:30, the patient had been getting dizzy spells daily since getting the vaccine. The patient felt like she was going to fall down sometimes. The patient has had no prior history of dizziness. No therapeutic measures were taken as a result of the event. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the event had been getting dizzy spells daily since getting the vaccine, felt like she was going to fall down sometimes was not resolved at the time of this report.   No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Vaccination site pain
Clinical narrative: Persistent headache starting ~24h post vaccination.; Fatigue starting ~24h post vaccination; Pain at injection site which cleared after 24 hrs; This is a spontaneous report from a contactable consumer, the patient. A non-pregnant female patient of unknown age received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EP6955) via an unspecified route of administration in the arm left on 13Apr2021 at 09:45 as a single dose for COVID-19 immunisation. The patient had no medical history. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EP6955) via an unspecified route of administration in the arm left on 23Mar2021 at 09:45 as a single dose for COVID-19 immunisation. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021 approximately 24 hours post vaccination, the patient experienced persistent headache and fatigue. On 14Apr2021, the patient had pain at injection site which cleared after 24 hours. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were taken as a result of the reported events which included treatment with acetaminophen. The clinical outcome of the events pain at injection site was recovered on 15Apr2021 after duration of 24 hours, while that of persistent headache and fatigue were not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 22.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal discomfort, Chills, Muscular weakness, Pyrexia
Clinical narrative: Chills; upset stomach; fever; weak legs; This is a spontaneous report received from a contactable consumer (patient's parent). A 22-year-old male patient received the second dose of BNT162B2 via an unspecified route of administration on the left arm on 13Apr2021 at 10:15 AM (Batch/Lot Number: Unknown) at the age of 22-year-old as single dose for COVID-19 immunization. Medical history included eczema and peanuts allergy. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Other medications the patient received within 2 weeks of vaccination included Allergy. COVID prior vaccination was none. COVID tested post vaccination was none. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medication was not reported. The patient previously received the first dose of BNT162B2 via an unspecified route of administration on the left arm on 23Mar2021 at 01:15 PM at the age of 22-year-old as single dose for COVID-19 immunization. On 14Apr2021, the patient experienced chills, upset stomach, fever and weak legs overnight only. Started late at night and went away when Advil was taken in the morning after. The patient became aware of this event on 14Apr2021 and reported it within 24 hours of learning of the event. The outcome of events was recovered.  No follow-up attempts are needed. Information about lot/batch number cannot be obtained.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Bad headache; This is a spontaneous report from a non-contactable consumer, the patient. A 56-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534), via an unspecified route of administration in the right arm on 25Mar2021 at 09:15 (at the age of 56-years-old), as a single dose for COVID-19 immunisation. Medical history included uterine cancer (tumor removed successfully with hysterectomy), chronic pain (back, both knees)-need surgeries and other orthopedic issues. The patient had unspecified known allergies. The patient received unspecified medications within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 25Mar2021 at 22:00, the patient experienced bad headache. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event bad headache was resolved on an unknown date in 2021.    No follow-up attempts are possible. No further information is expected.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Lymphadenopathy, Nausea, Pain
Clinical narrative: Chills; Aches; Nausea; Swollen lymph nodes; This is a spontaneous report from a non-contactable consumer, the patient. A 27-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the left arm on 14Apr2021 at 14:30 (at the age of 27-years-old) as a single dose for COVID-19 immunisation. The patient's medical history included psoriasis.  Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included ethinylestradiol, norethisterone (VYFEMLA); for an unknown indication on an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously took the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the left arm on 24Mar2021 at 14:30 (at the age of 27-years-old) as a single dose for COVID-19 immunisation. The patient previously took tramadol and codeine and experienced drug allergy on an unknown date. On 15Apr2021 at 08:00, the patient experienced chills, aches, nausea and swollen lymph nodes. The events resulted in doctor or other healthcare professional office/clinic visit. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of events chills, aches, nausea and swollen lymph nodes were not recovered at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Vertigo
Clinical narrative: Vertigo; Dizziness; This is a spontaneous report from a non-contactable consumer, the patient. A 42-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 10Apr2021 at 12:45 (at the age of 42-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient did not have allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 12Apr2021, the patient experienced vertigo and dizziness. No therapeutic measures were taken as a result of the reported adverse events. Since the vaccination, the patient had not been tested for COVID-19. The adverse events did not result in doctor or other healthcare professional office/clinic visit/ emergency visit. The clinical outcome of the event vertigo and dizziness was recovered on an unknown date in Apr2021.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Developed a rash on ankles, calves, hands, and underarm; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: et8730) via an unspecified route of administration in the left arm on 31Mar2021 at 10:45 (at the age of 45-year-old) as a single dose for COVID-19 immunisation. The patient was allergic to chlorohexadine, sulfa antibiotics and suspected penicillin. Concomitant medications included minoxidil (ROGAINE), multivitamins (MANUFACTURER UNKNOWN), fiber supplements (MANUFACTURER UNKNOWN) and probiotics (MANUFACTURER UNKNOWN)all for unknown indications from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient had not been diagnosed with COVID-19. On 01Apr2021 at 08:00 the patient developed a rash on ankles, calves, hands and underarm. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of occurred adverse events and included treatment with mupircin (MANUFACTURER UNKNOWN) and halobetasol (MANUFACTURER UNKNOWN). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event developed a rash on ankles, calves, hands, and underarm was recovering at this time of report.   No follow-up attempts are needed. No further information is expected.
Age: 32.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache, Myalgia
Clinical narrative: Headache; Muscle aches; Fatigue; This is a spontaneous report from a non-contactable consumer, the patient. A 32-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the left arm on 07Apr2021 at 13:45 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included paracetamol (TYLENOL) and loratadine (MANUFACTURER UNKNOWN). The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the left arm on 17Mar2021 at 14:30 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On an unknown date in Apr2021, after second jab the patient experienced headache, muscle aches, and fatigue, which were cleared up after 24 hours. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events headache, muscle aches, and fatigue were resolved on an unknown date in Apr2021.  No follow-up attempts are possible. No further information is expected.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, Dry throat, Euphoric mood, Feeling abnormal
Clinical narrative: lost sense of smell; lost sense of taste; 98.7F in the am, my normal temp 97.6; not feeling better; right superficial cervical lymph nodewas painful on touch and inflamed; Feels like bad sinus infection; felt excessive thirst; stuffed nose; dry throat; felt unusually energized; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the left arm on 09Apr2021 at 18:45 (at the age of 51-year-old) as a single dose for COVID-19 immunisation. Medical history included a sinus surgery in 1993. The patient did not have allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medication included paracetamol(TYLENOL) for unknown indication, two days prior to vaccination. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination.  On 11Apr2021 at 08:00, the patient experienced feeling of unusually energized, no body aches, no fever on day 1 and exactly after 24 hours of the shot, 18:45, the patient felt excessive thirst and on day 2 the patient woke up with stuffed nosed and dry throat, lymph nodes not inflamed but on day 3-4, the patient experienced 98.7F in the am whereas the patient normal temp was 97.6 and the patient felt only right superficial cervical lymph node was painful on touch and inflamed, felt like bad sinus infection. While on day 5 the patient had one lymph node still inflamed, was not feeling better, lost sense of smell and taste for about 12 hours, took a COVID test. On day 6, the sinus infection was getting worst. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the adverse event. On 19Mar2021, the patient underwent nasal swab and the result was negative. The clinical outcome of the event felt unusually energized was recovered within 24hours. The clinical outcome of the events lost sense of smell and lost sense of taste was recovered in about 12 hours. The clinical outcome of the events felt excessive thirst, stuffed nose, dry throat, right superficial cervical lymph node was painful on touch and inflamed, feels like bad sinus infection, not feeling better and 98.7F in the am, my normal temp 97.6 were not recovered at the time of the report.  No follow-up attempts are needed. No further information is expected.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Lymph node pain, Nasal congestion, Pyrexia, Sinusitis, Thirst
Clinical narrative: lost sense of smell; lost sense of taste; 98.7F in the am, my normal temp 97.6; not feeling better; right superficial cervical lymph nodewas painful on touch and inflamed; Feels like bad sinus infection; felt excessive thirst; stuffed nose; dry throat; felt unusually energized; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the left arm on 09Apr2021 at 18:45 (at the age of 51-year-old) as a single dose for COVID-19 immunisation. Medical history included a sinus surgery in 1993. The patient did not have allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medication included paracetamol(TYLENOL) for unknown indication, two days prior to vaccination. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination.  On 11Apr2021 at 08:00, the patient experienced feeling of unusually energized, no body aches, no fever on day 1 and exactly after 24 hours of the shot, 18:45, the patient felt excessive thirst and on day 2 the patient woke up with stuffed nosed and dry throat, lymph nodes not inflamed but on day 3-4, the patient experienced 98.7F in the am whereas the patient normal temp was 97.6 and the patient felt only right superficial cervical lymph node was painful on touch and inflamed, felt like bad sinus infection. While on day 5 the patient had one lymph node still inflamed, was not feeling better, lost sense of smell and taste for about 12 hours, took a COVID test. On day 6, the sinus infection was getting worst. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the adverse event. On 19Mar2021, the patient underwent nasal swab and the result was negative. The clinical outcome of the event felt unusually energized was recovered within 24hours. The clinical outcome of the events lost sense of smell and lost sense of taste was recovered in about 12 hours. The clinical outcome of the events felt excessive thirst, stuffed nose, dry throat, right superficial cervical lymph node was painful on touch and inflamed, feels like bad sinus infection, not feeling better and 98.7F in the am, my normal temp 97.6 were not recovered at the time of the report.  No follow-up attempts are needed. No further information is expected.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Lymph node pain, Lymphadenopathy
Clinical narrative: Large knot under arm, feel like lymph node; Large knot under arm that is tender to the touch, feel like lymph node; This is a spontaneous report from a contactable other healthcare professional, the patient. A 49-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0250) via an unspecified route of administration in the left arm on 10Apr2021 at 08:30 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 12Apr2021, the patient experienced large knot under the arm that was tender to the touch and felt like the lymph node. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as of result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events large knot under the arm that was tender to the touch and felt like the lymph node was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Headache, Nausea, SARS-CoV-2 test
Clinical narrative: Dizziness; Headache; Fatigue; Nausea; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the right arm on 01Apr2021 (at the age of 32-year-old) as a single dose for COVID-19 immunisation. Medical history included birth control. Concomitant medications included norethisterone (ERRIN) birth control from an unknown date indicated for birth control. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03Apr2021, the patient experienced dizziness, headache, fatigue and nausea. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had been tested for COVID-19. On 05Apr2021, the patient underwent nasal swab test and the result was negative. The clinical outcome of the events dizziness, headache, fatigue and nausea was not resolved at the time of report.  No follow-up attempts are needed. No further information is expected.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache, Oropharyngeal pain, Pain
Clinical narrative: Slight sore throat; Feel achy; Tired; Slight headache; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 14Apr2021 at 11:30 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. Medical history included parkinson's disease and blood pressure high. Patient had no known allergies. Concomitant medications included lisinopril (MANUFACTURER UNKNOWN), carbidopa; levodopa (CARBIDOPA/LEVODOPA) and rasagiline (MANUFACTURER UNKNOWN) all from an unknown date for an unspecified indication. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 22Mar2021 at 14:30 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021 at 20:30, the patient experienced felt achy and tired with slight headache. On 15Apr2021, the patient experienced felt achy, worse headache, tired and that evening had slight sore throat as well. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events felt achy and tired with slight headache, slight sore throat was recovering.  No follow-up attempts are needed. No further information is expected.
Age: 32.0
Sex: M
Vaccine: COVID19
Symptoms: Lethargy, Vaccination site pain
Clinical narrative: Tender armpit lymphnodes on side of injection site. Lethargy lasting 96+ hours; Lethargy lasting 96+ hours; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ew0151) via an unspecified route of administration in the left arm on 11Apr2021 at 09:45 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: er2613) via an unspecified route of administration in the left arm on 21Mar2021 at 09:45(at the age of 32-year-old) as a single dose for COVID-19 immunisation.  Prior to the vaccination, the patient had not been diagnosed with COVID-19. Since the vaccination, the patient had not been been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 11Apr2021 at 11:45, the patient experienced tender armpit lymph nodes on side of injection site and lethargy lasting 96 plus hours. Therapeutic measures were not taken as a result of these events. The clinical outcome of the event tender armpit lymph nodes on side of injection site and lethargy lasting 96 plus hours was recovering at this time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Migraine
Clinical narrative: Migraine; This is a spontaneous report from a non-contactable consumer, the patient. A 38-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 14Apr2021 at 11:30 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included montelukast sodium (SINGULAIR), budesonide, formoterol fumarate (SYMBICORT), cetirizine hydrochloride (ZYRTEC), fexofenadine hydrochloride (ALLEGRA) and famotidine (MANUFACTURER UNKNOWN); all from an unknown date for unknown indications. The patient previously took pertussis vaccine (MANUFACTURER UNKNOWN) and eletriptan hydrobromide (REPLAX) on unknown date for an unspecified indication and experienced drug allergy. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. On 15Apr2021 at 15:00, the patient experienced migraine. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of reported events which included treatment with acetaminophen (EXCEDRIN). The clinical outcome of the event migraine was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Lymph node pain, Lymphadenopathy, Pyrexia
Clinical narrative: Tender lymph node; Swollen lymph nodes; Fever; chills; Tired; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EM9809) via an unspecified route of administration in the left arm on 13Apr2021 at 09:15(at the age of 50-year-old) as a single dose for COVID-19 immunisation. Medical history included asthma, depression and food allergy(honey).The patient previously took nickel(MANUFACTURER UNKNOWN) on an unknown date and for unknown indication and experienced drug allergy. The patient previously took povidone-iodine(BETADINE) on an unknown date and for unknown indication and experienced drug allergy. The patient previously took neomycin sulfate; polymyxin b sulfate; gramicidin(NEOSPORIN) on an unknown date and for unknown indication  and experienced drug allergy.  Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included sertraline hydrochloride (ZOLOFT), meloxicam (MOBIC) and montelukast sodium (SINGULAIR) all from unknown date for unknown indication. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021 the patient experienced swollen, tender lymph node, fever, chills and tired. No therapeutic measures were taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19.  The clinical outcome of the events swollen, tender lymph node, fever, chills and tired were resolving at the time of the report.  No follow-up attempts are needed. No further information is expected.
Age: 27.0
Sex: M
Vaccine: COVID19
Symptoms: Pain, Swelling
Clinical narrative: Swollen near armpit (left arm); Does hurt; This is a spontaneous report from a non-contactable consumer, the patient. A 27-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EWO15C) via an unspecified route of administration in the left arm on 14Apr2021 at 01:00 (at the age of 27-years-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medication within two weeks of the COVID-19 vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 24March2021 (at the age of 27-years-old) as a single dose for COVID-19 immunisation The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 14Apr2021 at 16:00, the patient experienced swelling near armpit (left arm) which hurt. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events swelling near armpit (left arm) which hurt was not resolved at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure measurement, Burning sensation, Headache, Hypertension, Lip swelling
Clinical narrative: High blood pressure, normally is 105/70, went up to 155/110.; Severe headaches for 3 days.; Sore mouth; burning sensation inside my mouth; swollen lips; herpes like rush on my lips, inside and outside of my nose but only on the left side; herpes like rush on my lips, inside and outside of my nose but only on the left side; This is a spontaneous report from a non-contactable consumer. This 55-year-old female consumer (patient) reported for self. A 55-year-old non pregnant female patient received bnt162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE Solution for injection Lot Number: ER8733) via an unspecified route of administration on 05Apr2021 10:00 as dose number unknown, single (age at vaccination: 55 years) for COVID-19 immunisation. Medical history included none relevant history. Concomitant medications were not reported. No other vaccine in four weeks and no other medications in two weeks. No COVID prior vaccination and did not test COVID post vaccination. No known allergies. On 05Apr2021 07:00 PM, the patient experienced high blood pressure, normally is 105/70, went up to 155/110. Severe headaches for 3 days. Sore mouth, burning sensation inside my mouth, swollen lips, herpes like rush on my lips, inside and outside of my nose but only on the left side. No treatment was received. The patient underwent lab tests and procedures which included blood pressure resulted as 105/70 high and 155/110 high both on 05Apr2021. The clinical outcome of the event was resolved.  No follow-up attempts are possible. No further information is expected.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Nasal herpes, Oral herpes, Oral pain
Clinical narrative: High blood pressure, normally is 105/70, went up to 155/110.; Severe headaches for 3 days.; Sore mouth; burning sensation inside my mouth; swollen lips; herpes like rush on my lips, inside and outside of my nose but only on the left side; herpes like rush on my lips, inside and outside of my nose but only on the left side; This is a spontaneous report from a non-contactable consumer. This 55-year-old female consumer (patient) reported for self. A 55-year-old non pregnant female patient received bnt162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE Solution for injection Lot Number: ER8733) via an unspecified route of administration on 05Apr2021 10:00 as dose number unknown, single (age at vaccination: 55 years) for COVID-19 immunisation. Medical history included none relevant history. Concomitant medications were not reported. No other vaccine in four weeks and no other medications in two weeks. No COVID prior vaccination and did not test COVID post vaccination. No known allergies. On 05Apr2021 07:00 PM, the patient experienced high blood pressure, normally is 105/70, went up to 155/110. Severe headaches for 3 days. Sore mouth, burning sensation inside my mouth, swollen lips, herpes like rush on my lips, inside and outside of my nose but only on the left side. No treatment was received. The patient underwent lab tests and procedures which included blood pressure resulted as 105/70 high and 155/110 high both on 05Apr2021. The clinical outcome of the event was resolved.  No follow-up attempts are possible. No further information is expected.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Fatigue, Headache, Hyperhidrosis, Myalgia
Clinical narrative: Vomiting; Weakness; Muscle soreness; Sweating; Headache; Nausea; Tiredness; Soreness at the injection site; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the right arm on 14Apr2021 at 13:30 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. Medical history included Charcot Marie tooth disease, bilateral foot drop, hip dysplasia, manic bipolar depression and anxiety. The patient had known allergies to latex. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included cariprazine hydrochloride (VRAYLAR), levetiracetam (KEPPRA), clonazepam (KLONOPIN), codeine phosphate, paracetamol (TYLENOL WITH CODEINE) and citalopram hydrobromide (CELEXA); all from unknown dates for unknown indications and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021, the patient experienced immediate reaction at the pharmacy which included sweating, headache and nausea. The patient left the pharmacy, went home and got really tired and soreness at the injection site. On 15Apr2021, the patient woke up the next morning after vaccination and still felt very fatigued, headache, vomiting, muscle soreness, weakness and continued soreness at the injection site. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events sweating, headache, nausea, soreness at injection site, fatigue, vomiting, muscle soreness and weakness was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Vaccination site pain, Vomiting
Clinical narrative: Vomiting; Weakness; Muscle soreness; Sweating; Headache; Nausea; Tiredness; Soreness at the injection site; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the right arm on 14Apr2021 at 13:30 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. Medical history included Charcot Marie tooth disease, bilateral foot drop, hip dysplasia, manic bipolar depression and anxiety. The patient had known allergies to latex. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included cariprazine hydrochloride (VRAYLAR), levetiracetam (KEPPRA), clonazepam (KLONOPIN), codeine phosphate, paracetamol (TYLENOL WITH CODEINE) and citalopram hydrobromide (CELEXA); all from unknown dates for unknown indications and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021, the patient experienced immediate reaction at the pharmacy which included sweating, headache and nausea. The patient left the pharmacy, went home and got really tired and soreness at the injection site. On 15Apr2021, the patient woke up the next morning after vaccination and still felt very fatigued, headache, vomiting, muscle soreness, weakness and continued soreness at the injection site. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events sweating, headache, nausea, soreness at injection site, fatigue, vomiting, muscle soreness and weakness was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Hemiplegic migraine, Urticaria
Clinical narrative: Hives; Complex (Hemiplegic ) Migraine; This is a spontaneous report from a contactable consumer, the patient. A 36-years-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 05Apr2021 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. Medical history included asthmatic, acid reflux, endometriosis, collapsed lung and allergy to steroids. The patient previously received acetylsalicylic acid (ASPIRIN) on an unspecified date for an unknown indication and experienced drug allergy. Concomitant medications were not reported.  Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Apr2021, the patient experienced hives and complex (Hemiplegic) migraine. The event resulted in emergency room/department or urgent care. Therapeutic measures were taken as a result of events and included treatment with Benadryl. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event hives and complex (Hemiplegic) migraine was recovered on an unknown date in Apr2021.   No follow-up attempts are needed. No further information is expected.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Lymph node pain, Swelling, Vaccination site pain
Clinical narrative: Lymph node tenderness; Swelling left armpit (same side as injection).; Injection site soreness; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration in the left arm on 12Apr2021 at 08:15 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. The patients' medical history included hypothyroid, COPD (chronic obstructive pulmonary disease) and tachycardia. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient had no known allergies to medications, food, or other products. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN) and vitamin d nos (5000) (MANUFACTURER UNKNOWN); both from unknown dates for unspecified indications and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6206), via an unspecified route of administration in the left arm on 22Mar2021 at 08:30 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 12Apr2021, the patient experienced injection site soreness on the day of vaccine and the day after that. On 15Apr2021 at 04:30, the patient experienced lymph node tenderness, swelling in the left armpit (same side as injection) which began on day three after the injection. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events vaccination site soreness, lymph node tenderness and swelling in left armpit (same side as injection) was resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Case of shingles; This is a spontaneous report from a non-contactable consumer, the patient. A 34-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 31Mar2021 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications taken within two weeks of vaccination were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Apr2021, the patient experienced a case of shingles. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the event shingles and included treatment with Antiviral. The clinical outcome of the event shingles was unknown at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Pain, Pyrexia
Clinical narrative: During the night starting feeling achy; Chills; Fever <100 degrees; This is a spontaneous report from a contactable consumer. A 43-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration on 13Apr2021 at 11:30 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration on 23Mar2021 as a single dose for COVID-19 immunisation. On 14Apr2021, during the night at 02:00, the patient felt achy, chills, fever of <100 centigrade. The events did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. On 14Apr2021 at 02:00, the patient underwent body temperature test and the result was <100 degrees. No therapeutic measures were taken for the reported events. The clinical outcome of the events during the night starting feeling achy, chills and fever <100 degrees was resolved on an unknown date of Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Breast tenderness
Clinical narrative: This is a spontaneous report from a contactable consumer (patient). A 48-year-old (non-pregnant)  female patient received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot# ER8733), at the age of 48, via an unspecified route of administration, left arm, on Apr 13, 2021, at 09:30, single dose, for COVID-19 immunisation. Medical history: none. The patient has known allergies to Phenergan (promethazine). Prior to the vaccination, patient was not diagnosed with COVID-19. Concomitant medications included Vitamin D3 (cholecalciferol), fish oil, potassium chloride, aluminum hydroxide, magnesium hydroxide and probiotic; all from unknown dates, for unknown indications and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On Apr 13, 2021, at 22:00, patient experienced very tender breasts. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures taken as a result of the event. Since the vaccination, patient has not tested for COVID-19. The outcome of very tender breasts: not recovered (at the time of this report). No follow-up attempts needed. No further information expected.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphoedema, Pain in extremity, Vaccination site pain
Clinical narrative: Injection site pain; hard pain on right arm; lymphedema in my right arm; This is a spontaneous report from a contactable other healthcare professional. A 41-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration in the arm right on 14Apr2021 at 08:30(at the age of 41-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient did not receive any medication within two weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021 at 21:00, the patient experienced injection site pain, hard pain on right arm and lymphedema in right arm. The patient did not receive any treatment for the reported events. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. The clinical outcome of the event injection site pain, hard pain on right arm and lymphedema in right arm were not recovered at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain in extremity
Clinical narrative: Pain in arm; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 28-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) via an unspecified route of administration in  the right arm on 15Apr2021 at 16:15(at the age of 28-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma and high cholesterol. Concomitant medications included formoterol fumarate, mometasone furcate (DULERA) from unknown date for unspecified indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15Apr2021 at 17:00 the patient experienced sore arm and fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. The clinical outcome of the event pain in arm and fatigue was recovered with sequelae.   No follow-up attempts are needed. No further information is expected.